Grail In Brief This Week: Meridian Bioscience, BioMérieux, Applied DNA Sciences, More News items for the week of Dec. 12, 2022. European Commission Outlines Intended Restorative Measures for Blocked Illumina-Grail Deal In a Statement of Objections, the agency laid out the intended divestment and transitional measures for Illumina to unwind and dissolve the Grail acquisition. Illumina Lowers FY 2022 Guidance as Q3 Revenues Rise 1 Percent Illumina is taking a $3.91 billion write-off related to Grail triggered by regulatory decisions in Europe, resulting in a net loss for the quarter. In Brief This Week: Thermo Fisher Scientific, Enzo Biochem, Codex DNA, More News items for the week of Oct. 10, 2022. ESMO Data Sharpens View of How Grail, Exact Sciences Multi-Cancer Early Detection Tests Perform Premium Grail released updated data on Galleri from the PATHFINDER study, while Exact reported retrospective analysis on the performance of its test. Sep 6, 2022 EU to Disallow Illumina's Grail Purchase Sep 1, 2022 Illumina Says Judge Issued Favorable Decision in FTC Challenge to Grail Acquisition Aug 12, 2022 Illumina Lowers 2022 Guidance, Braces for Fines from European Commission Premium Jul 19, 2022 European Commission Says Illumina 'Jumped the Gun' With Grail Deal, Threatens Fines Jul 15, 2022 In Brief This Week: Centogene, Novacyt, T2 Biosystems, Inotiv, Oxford Nanopore, More Jul 13, 2022 Illumina Loses Bid to Halt European Review of Grail Deal Jul 1, 2022 In Brief This Week: Pacific Biosciences, Invitae, Grail, Mainz Biomed, Molzym, More Jun 3, 2022 In Brief This Week: Labcorp, Grail, AnPac Bio-Medical, CDC, Agilent Technologies, More Jun 2, 2022 Grail, AstraZeneca Partner on Companion Dx for Oncology Drugs May 31, 2022 Grail, Veterans Affairs to Evaluate Galleri Cancer Early Detection Test May 27, 2022 Guardant Health Files Motions to Dismiss, Change Venue in Illumina Patent Lawsuit May 16, 2022 Intermountain Healthcare Rolling Out Galleri Multi-Cancer Early Detection Test in Pilot Program Premium May 6, 2022 Illumina Provides Updates on China Business, Grail, Upcoming Sequencing Chemistries Premium May 5, 2022 Illumina Q1 Revenues Grow 12 Percent Feb 15, 2022 Point32Health to Offer Grail Cancer Early Detection Test Under Pilot Program Feb 10, 2022 Illumina Q4 Revenues Grow 26 Percent, Full-Year 2021 Revenues Jump 40 Percent Jan 11, 2022 Illumina Touts New Partnerships, Sequencing Technology at JP Morgan Healthcare Conference Jan 10, 2022 Grail Partners With Premier's PINC AI to Improve Patient Access to Blood-Based Multi-Cancer Test Nov 5, 2021 Oncology Opportunities Provide 'Pot of Gold at the End of the Double Rainbow' for Illumina Premium Nov 4, 2021 Illumina Q3 Revenues Grow 40 Percent Load More Breaking News Simple HealthKit Raises $8M in Series A Round Top Five Articles on GenomeWeb Last Week: Quantum-Si Layoffs, UBS Coverage Initiations, More LumiraDx Secures FDA Emergency Use Authorization, UK Approval for COVID-19, Flu Test Rarity Bioscience Raises Additional €500,000 Cancer Prognoses Informed by Module-Based Approach, Study Finds The Scan UK Team Presents Genetic, Epigenetic Sequencing Method Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers. DNA Biobank Developed for French Kidney Donors, Recipients The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France. Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site. Study Reveals New Details About Genetics of Major Cause of Female Infertility Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.